Close Menu
Home » RNAssist Licenses Biomolecule Stabilization Tech to QCMD

RNAssist Licenses Biomolecule Stabilization Tech to QCMD

Jan 23, 2020
|
staff reporter

NEW YORK – UK-based technology development company RNAssist said this week that it has licensed its VivoPhix biomolecule stabilization technology to Quality Control for Molecular Diagnostics (QCMD).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letter Condemns Virus Conspiracy Theories

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

Philip Leder Dies

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

New and Maybe Important

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

Nucleic Acids Research Studies on Alu Genotyping, Stress Response Histones, Undocumented Small RNAs

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.

What's Popular?

In Business News

  1. 10x Genomics Q4 Revenues Grow 49 Percent

  2. Twist Bioscience Announces $100M Public Stock Offering

  3. Natera Countersues CareDx for False Advertising

  4. 10x Genomics Previews New Product Lineup Ahead of AGBT

    Premium

  5. S2 Genomics, Riken Partner on Single-Cell Genomics Applications

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.